Revenue · 2015–2025
Ascendis Pharma revenue
$814M+106.7% · FY2025
Ascendis Pharma (ASND) reported $814M in revenue for fiscal 2025, +106.7% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $814M | +106.7% | Open → |
| FY20242024-12-31 | $394M | +36.5% | Open → |
| FY20232023-12-31 | $288M | +435.2% | Open → |
| FY20222022-12-31 | $53.9M | +485.8% | Open → |
| FY20212021-12-31 | $9.2M | +15.8% | Open → |
| FY20202020-12-31 | $7.9M | −47.0% | Open → |
| FY20192019-12-31 | $15.0M | +19.8% | Open → |
| FY20182018-12-31 | $12.5M | +623.0% | Open → |
| FY20172017-12-31 | $1.7M | −66.1% | Open → |
| FY20162016-12-31 | $5.1M | −43.4% | Open → |
| FY20152015-12-31 | $9.0M | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +56.9%
Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ascendis Pharma revenue |url=https://companiesranked.com/en/company/ascendis-pharma/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ascendis Pharma revenue. CompaniesRanked. https://companiesranked.com/en/company/ascendis-pharma/revenueBibTeX
@misc{companiesranked-en-company-ascendis-pharma-revenue-2026,
author = {{CompaniesRanked}},
title = {{Ascendis Pharma revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ascendis-pharma/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-046590 · February 11, 2026
{{cite web |title=Ascendis Pharma revenue — 20-F (0001193125-26-046590) |url=https://www.sec.gov/Archives/edgar/data/1612042/000119312526046590/asnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-11}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.